Anemia.
Turner J, Parsi M, Badireddy M.
2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Anemia in chronic kidney disease.
Atkinson MA, Warady BA.
Pediatr Nephrol. 2018 Feb;33(2):227-238. doi: 10.1007/s00467-017-3663-y. Epub 2017 Apr 15.
Pathophysiology, mechanisms, and managements of tissue hypoxia.
Mallat J, Rahman N, Hamed F, Hernandez G, Fischer MO.
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101087. doi: 10.1016/j.accpm.2022.101087. Epub 2022 Apr 21.
Rubrometabolic Syndrome.
Kalra S, Coetzee A, Kalra PA, Saldaña JR, Kilov G.
Minerva Endocrinol (Torino). 2023 Mar;48(1):59-75. doi: 10.23736/S2724-6507.20.03353-2. Epub 2020 Dec 17.
Erythropoietin.
Jelkmann W.
J Endocrinol Invest. 2003 Sep;26(9):832-7. doi: 10.1007/BF03345232.
Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia begin?
Köhler D, Voshaar T, Stais P, Haidl P, Dellweg D.
Dtsch Med Wochenschr. 2023 Apr;148(8):475-482. doi: 10.1055/a-2007-5450. Epub 2023 Mar 29.
Neuropathology of cerebrovascular diseases.
Ferrer I, Vidal N.
Handb Clin Neurol. 2017;145:79-114. doi: 10.1016/B978-0-12-802395-2.00007-9.
Use of molidustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, in chronic kidney disease-associated anemia in cats.
Charles S, Süssenberger R, Settje T, Langston C, Lainesse C.
J Vet Intern Med. 2024 Jan-Feb;38(1):197-204. doi: 10.1111/jvim.16807. Epub 2023 Sep 22.
Anemic hypoxemia reduces myoblast proliferation and muscle growth in late-gestation fetal sheep.
Rozance PJ, Wesolowski SR, Jonker SS, Brown LD.
Am J Physiol Regul Integr Comp Physiol. 2021 Sep 1;321(3):R352-R363. doi: 10.1152/ajpregu.00342.2020. Epub 2021 Jul 21.
Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis.
Yang J, Xing J, Zhu X, Xie X, Wang L, Zhang X.
Front Endocrinol (Lausanne). 2023 Mar 16;14:1131516. doi: 10.3389/fendo.2023.1131516. eCollection 2023.
